What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Statistics
- Surgery
Lloyd D. Fisher spends much of his time researching Internal medicine, Cardiology, Surgery, Coronary artery disease and Coronary artery surgery.
He combines topics linked to Gastroenterology with his work on Internal medicine.
His Cardiology study is mostly concerned with Artery, Heart failure, Angina, Myocardial infarction and Stenosis.
His studies examine the connections between Surgery and genetics, as well as such issues in Bone marrow, with regards to Ganciclovir, Neutropenia, Chemotherapy, Letermovir and Liver transplantation.
His Coronary artery disease research incorporates elements of Endocrinology, Elective surgery, Electrocardiography, Lipoprotein and Laropiprant.
His Coronary artery surgery study integrates concerns from other disciplines, such as Bypass grafts, Graft patency, Quality of life and Anastomosis.
His most cited work include:
- Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein B (2017 citations)
- Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. (1702 citations)
- Continual reassessment method: a practical design for phase 1 clinical trials in cancer. (1140 citations)
What are the main themes of his work throughout his whole career to date?
Lloyd D. Fisher focuses on Internal medicine, Cardiology, Surgery, Statistics and Coronary artery disease.
His study in Myocardial infarction, Disease, Stenosis, Ejection fraction and Survival rate is done as part of Internal medicine.
The study incorporates disciplines such as Coronary heart disease and Sudden death in addition to Myocardial infarction.
His Artery, Angina, Coronary artery surgery, Chest pain and Heart failure investigations are all subjects of Cardiology research.
His Surgery course of study focuses on Clinical trial and Randomized controlled trial.
His Statistics research focuses on Econometrics and how it connects with Survival analysis.
He most often published in these fields:
- Internal medicine (43.86%)
- Cardiology (35.53%)
- Surgery (23.68%)
What were the highlights of his more recent work (between 1999-2014)?
- Statistics (16.23%)
- Econometrics (7.89%)
- Internal medicine (43.86%)
In recent papers he was focusing on the following fields of study:
Lloyd D. Fisher mainly investigates Statistics, Econometrics, Internal medicine, Intensive care medicine and Heart failure.
His research in Statistics intersects with topics in Series and Clinical evidence.
The concepts of his Internal medicine study are interwoven with issues in Oncology and Cardiology.
His Cardiology research is multidisciplinary, incorporating perspectives in Simvastatin, Metabolic syndrome and Niacin.
Lloyd D. Fisher has included themes like Levosimendan, Heart disease and Surgery, Chemotherapy in his Intensive care medicine study.
His work in the fields of Coronary artery surgery and Operative mortality overlaps with other areas such as Arnold-Chiari syndrome and Central alveolar hypoventilation.
Between 1999 and 2014, his most popular works were:
- Effect of Levosimendan on the Short-Term Clinical Course of Patients With Acutely Decompensated Heart Failure (276 citations)
- Exercise Stress Testing (150 citations)
- Active-control trials: How would a new agent compare with placebo? A method illustrated with clopidogrel, aspirin, and placebo (74 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Statistics
- Surgery
His primary scientific interests are in Internal medicine, Levosimendan, Heart failure, Cardiology and Placebo.
His study in Diagnostic accuracy, Exercise stress testing, Stress testing, Coronary arteriography and Disease falls under the purview of Internal medicine.
His study focuses on the intersection of Levosimendan and fields such as Intensive care medicine with connections in the field of Loading dose.
Lloyd D. Fisher studies Cardiology, namely Coronary artery disease.
His Placebo research includes themes of Clopidogrel, Relative risk reduction and Anesthesia.
The Anesthesia study combines topics in areas such as Odds ratio, Confidence interval, Stroke, Myocardial infarction and Aspirin.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
